COVID-19 Vaccines: Global Regulators Define Preclinical Data Requirements
Address Thorny Issue Of Studying Vaccine-Induced Disease Enhancement
Regulators held a virtual meeting to agree on the type and extent of preclinical data needed to inform the clinical development of vaccines for COVID-19.
